Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.38 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.37 |
| ▸ | CDC25A | P30304 | 1/20 | 0.37 |
| ▸ | CDC25B | P30305 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MYC | P01106 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11699744 | 0.87 | KDM4E (0.44) | ALDH1A1KDM4ETSHRMAPK1PTPN11 | |
| SCHEMBL4885779 | 0.87 | ALDH1A1 (0.50) | ALDH1A1KDM4ETSHRMAPK1LMNA | |
| SCHEMBL1308816 | 0.82 | ALDH1A1 (0.61) | ALDH1A1KDM4ETSHRMAPK1LMNA | |
| Terephthalic Acid SCHEMBL8439001 | 0.82 | MAPT (0.49) | ALDH1A1TSHRMAPK1PLA2G4BTP53 | |
| SCHEMBL2061233 | 0.82 | MAPT (0.49) | ALDH1A1TSHRMAPK1PLA2G4BTP53 | |
| SCHEMBL1960510 | 0.80 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPK1PTPN11PLA2G4B | |
| SCHEMBL18096524 | 0.80 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPK1PTPN11PLA2G4B | |
| SCHEMBL2284064 | 0.80 | ALDH1A1 (0.55) | ALDH1A1TSHRMAPK1PTPN11PLA2G4B | |
| SCHEMBL2185343 | 0.79 | KMT2A (0.48) | ALDH1A1LMNARAB9APLA2G4BTP53 | |
| SCHEMBL2920879 | 0.79 | KDM4E (0.45) | ALDH1A1KDM4ETSHRMAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220211725-A1 | Pharmaceutical Composition Comprising Venetoclax | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2022-07-07 | — | — | US | claimed |
| WO-2020225738-A1 | PHARMACEUTICAL COMPOSITION COMPRISING VENETOCLAX | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2020-11-12 | — | — | WO | claimed |
| EP-1847257-B1 | Solid preparation comprising enteric solid dispersion | SHINETSU CHEMICAL CO (JP) | 2017-11-22 | — | — | EP | claimed |
| US-20140370091-A1 | Method for Producing Aqueous Enteric Coating Liquid, Solid Preparation, and Method for Producing Same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-18 | — | — | US | claimed |
| EP-2813218-A1 | Method for producing aqueous enteric coating liquid, solid preparation, and method for producing same | Shin-Etsu Chemical Co., Ltd. (JP) | 2014-12-17 | — | — | EP | claimed |
| US-20080038340-A1 | Solid dosage form of enteric solid dispersion and method for producing the same | SHIN-ETSU CHEMICAL CO., LTD. | 2008-02-14 | — | — | US | claimed |
| EP-1886673-A2 | Solid dosage form of enteric solid dispersion and method for producing the same | Shin-Etsu Chemical Co., Ltd. (JP) | 2008-02-13 | — | — | EP | claimed |
| US-20070248682-A1 | SOLID PREPARATION COMPRISING ENTERIC SOLID DISPERSION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-10-25 | — | — | US | claimed |
| EP-1847257-A2 | Solid preparation comprising enteric solid dispersion | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-10-24 | — | — | EP | claimed |
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION | 2025-07-31 | — | — | US | disclosed |
| EP-4479092-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | Purdue Research Foundation (US) | 2024-12-25 | — | — | EP | disclosed |
| WO-2023154171-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20220211725-A1 | Pharmaceutical Composition Comprising Venetoclax | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2022-07-07 | — | — | US | disclosed |
| US-11292793-B2 | Solid dispersions of amorphous Lumateperone p-Tosylate | DR. REDDY'S LABORATORIES LIMITED (IN) | 2022-04-05 | — | — | US | disclosed |
| US-20080038340-A1 | Solid dosage form of enteric solid dispersion and method for producing the same | SHIN-ETSU CHEMICAL CO., LTD. | 2008-02-14 | — | — | US | disclosed |
| EP-1886673-A2 | Solid dosage form of enteric solid dispersion and method for producing the same | Shin-Etsu Chemical Co., Ltd. (JP) | 2008-02-13 | — | — | EP | disclosed |
| US-20070248682-A1 | SOLID PREPARATION COMPRISING ENTERIC SOLID DISPERSION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1847257-A2 | Solid preparation comprising enteric solid dispersion | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-10-24 | — | — | EP | disclosed |
| US-20070196399-A1 | ENTERIC-COATED PREPARATION COVERED WITH ENTERIC COATING MATERIAL FOR SITE-SPECIFIC DELIVERY OF DRUG TO SITE WITHIN THE SMALL INTESTINE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| EP-1820498-A2 | Enteric-coated preparation for site-specific delivery of drug to site within the small intestine | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11292793-B2 | Solid dispersions of amorphous Lumateperone p-Tosylate | HTR2A, HTR2C, HTR1A | ALDH1A1 2652/4885KDM4E 3180/4885TSHR 100/4885 |
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | SRI, SYNGR2, PSD | ALDH1A1 3898/4885KDM4E 835/4885TSHR 4586/4885 |
| US-20220211725-A1 | Pharmaceutical Composition Comprising Venetoclax | U2AF1, SF3B1, SF3B3 | ALDH1A1 3436/4885KDM4E 1233/4885TSHR 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.